Unless otherwise stated, this product is intended for research use only. It is not suitable for any other purpose, which includes, but is not limited to, unauthorized commercial use, in vitro diagnostic use, or therapeutic use in humans or animals.
Przejdź do
O5015
Oxybutynin chloride
meets EP, USP testing specifications
Synonim(y):
α-Phenylcyclohexaneglycolic acid 4-(diethylamino)-2-butynyl ester hydrochloride
Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.
Informacje o tej pozycji
Wzór empiryczny (zapis Hilla):
C22H31NO3 · HCl
Numer CAS:
Masa cząsteczkowa:
393.95
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12161900
EC Number:
216-139-7
MDL number:
Quality Segment
agency
USP/NF, meets EP testing specifications, meets USP testing specifications
form
solid
application(s)
pharmaceutical (small molecule)
storage temp.
room temp
SMILES string
Cl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2
InChI
1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H
InChI key
SWIJYDAEGSIQPZ-UHFFFAOYSA-N
Gene Information
human ... CHRM2(1129), CHRM3(1131)
Biochem/physiol Actions
Muscarinic acetylcholine receptor antagonist.
Muscarinic acetylcholine receptor antagonist; inhibits proliferation of bladder smooth muscle cells, perhaps by downregulation of growth promoting genes.
Ta strona może zawierać tekst przetłumaczony maszynowo.
1 of 1
Ta pozycja | |||
|---|---|---|---|
| form solid | form - | form - | form solid |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical small molecule |
| storage temp. room temp | storage temp. 2-8°C | storage temp. - | storage temp. 2-30°C |
| Quality Level 200 | Quality Level - | Quality Level - | Quality Level 300 |
| agency USP/NF, meets USP testing specifications, meets EP testing specifications | agency - | agency - | agency traceable to Ph. Eur. O0288000, traceable to USP 1485103 |
| Gene Information human ... CHRM2(1129), CHRM3(1131) | Gene Information human ... CHRM2(1129), CHRM3(1131) | Gene Information human ... CHRM2(1129), CHRM3(1131) | Gene Information - |
Still not finding the right product?
Explore all of our products under Oxybutynin chloride
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
Klasa składowania
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.
K-S Lee et al.
International journal of clinical practice, 66(7), 663-670 (2012-06-16)
Standardised traditional outcome measures may fail to address factors that are important to patients and address irrelevant factors. Aim of this study was to assess patient-reported goals and goal achievement (GA) in the antimuscarinic treatment for overactive bladder (OAB) patients.
Lorne E Aaron et al.
Current medical research and opinion, 28(8), 1369-1379 (2012-07-10)
Evaluate patient and physician satisfaction with a novel formulation of a once-daily controlled-release (CR) oxybutynin (Uromax*) 15-mg tablet as both the initial and maintenance dose in elderly and non-elderly patients with overactive bladder (OAB). Patients not on anticholinergic treatment for
V Schuler et al.
Phytomedicine : international journal of phytotherapy and phytopharmacology, 19(10), 947-951 (2012-07-25)
A broad spectrum of synthetic agents is available for the treatment of overactive bladder. Anti-cholinergic drugs show a poor compliance due to side effects. There is an increasing use of plant extracts in medicine. We have therefore investigated the inhibitory
Numer pozycji handlu globalnego
| SKU | NUMER GTIN |
|---|---|
| O5015-5G | 04061833429235 |
| O5015-1G | 04061826695128 |
| O5015-500MG | 04061833435571 |
-
what side effects are there.
1 answer-
Helpful?
-